Skip to content
WeighLab
Menu
Ranked #369 · Grade C

VivioMD review

VivioMD is a nationwide GLP-1 telehealth platform (49 states, excluding Louisiana) offering both compounded semaglutide/tirzepatide and FDA-approved Ozempic/Zepbound, dispensed through four named pharmacy partners.

Visit VivioMD Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
Not disclosed
Tirzepatide
Not disclosed
Coverage
All 50 states
Brand-name
Yes

Pricing verified August 2026

The Index scorecard

VivioMD scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month45/100
Price Transparency20/100
Nationwide Access86/100
Formulation Options53/100
Clinical Oversight68/100
Contract Flexibility55/100

Where the value is

  • Offers both compounded AND FDA-approved branded GLP-1s (Ozempic, Zepbound) -- more flexibility than compounded-only competitors
  • Four named pharmacy partners disclosed by name, more transparency than most peers
  • Broad state coverage -- 49 states, only Louisiana excluded
  • LegitScript approval badge displayed, described as 'independently verified telehealth'

The tradeoffs

  • No pricing whatsoever is published -- every price is gated behind a full intake assessment
  • No medical director name disclosed anywhere on the accessible pages
  • Cannot pre-shop or comparison-shop on price before committing time to the funnel
  • 'Flat pricing -- never goes up as your dose increases' is an unverifiable claim with no actual numbers to check it against
  • FDA issued VivioMD Group LLC dba VivioMD a warning letter in June 2026; the letter is public in FDA's warning-letter database

The bottom line

Best for: Shoppers who want both compounded and FDA-approved GLP-1 options from one nationwide platform, and don't mind completing an intake before seeing price. VivioMD is a nationwide GLP-1 telehealth platform (49 states, excluding Louisiana) offering both compounded semaglutide/tirzepatide and FDA-approved Ozempic/Zepbound, dispensed through four named pharmacy partners.

Ranked #369 of 539 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 538 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to VivioMD.

The 18 programs nearest this one

Pricing, states and verification reflect VivioMD's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on VivioMD's site. Not medical advice; see our disclosure.

← Back to the value leaderboard